MedTrace Logo

Acceptability and Tolerance Study of Peptide Feed with Fibre

NCT06102135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-09-23

No results posted yet for this study

Summary

Enterally fed adults with documented evidence of gastrointestinal intolerance will be recruited. Participants will be deemed by the investigator as having a clinical indication for enteral feeding with a fibre containing peptide formula. Data from 15 participants are required in order to submit an application to the Advisory Committee on Borderline Substances (ACBS) for product registration.

Conditions

  • Dietary Exposure

Interventions

DIETARY_SUPPLEMENT

Peptamen 1.3 PHGG

The amount of tube feed will be assess by the health Care Professional.

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Stephanie Wakefield · Newcastle Upon Tyne Hospital Trust

  • Nirouz Zarroug · Liverpool university Hospital Trust

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-05
Primary Completion
2024-09-03
Completion
2024-09-03

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06102135 on ClinicalTrials.gov